Repligen Corp (NAS:RGEN)
$ 171.78 -0.16 (-0.09%) Market Cap: 9.60 Bil Enterprise Value: 9.56 Bil PE Ratio: 687.12 PB Ratio: 4.87 GF Score: 93/100

Repligen Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 02:10PM GMT
Release Date Price: $207.97 (+0.79%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. I'm Tycho Peterson. It's my pleasure to introduce our next company this morning, Repligen. (Operator Instructions)

And with that, let me turn it over to Tony.

Anthony J. Hunt
Repligen Corporation - CEO, President & Director

Thanks, Tycho, and appreciate the opportunity again this year to present at the JPMorgan conference. Goal today will be to bring everybody up to speed on all the activities at Repligen over the last 12 months, talk a little bit about 2021 and set the stage for the next 3 to 5 years.

But before jumping in, I just want to take a moment to reach out and thank all the Repligen employees. As everybody knows, 2020 was an incredibly challenging year. Our team did a phenomenal job, basically kept all our manufacturing sites open, all our service support sales, customer service people out working with customers. So from myself, from the management team, just a big thank you from all of us.

So jumping into the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot